Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

3

SEC Filing Details

Document Details

Form
Filing Date
Sep 6, 2019
Document Date
Sep 4, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.
Filer
Wagner Heidi L